Sanofi and GlaxoSmithKline, two of the world’s biggest vaccine players, may be competitors, but the COVID-19 pandemic has now made them partners.

They aim to start human testing in the second half of this year, and if all goes well, to file for potential approvals by the second half of 2021. Source: Fierce Biotech 14/4/2020